Contact
Please use this form to send email to PR contact of this press release:
CytoDyn Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab
TO:
Please use this form to send email to PR contact of this press release:
CytoDyn Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab
TO: